Clinical Updates

Celldex Therapeutics Inc said its experimental vaccine for the most common type of brain cancer met the main goal of… »   

Kidney disease patients treated with Merck & Co Inc’s cholesterol-lowering drug Vytorin were about 16 percent less likely to have… »   

It’s not often that spontaneous applause erupts halfway through a scientific talk. But when malaria researcher Arjen Dondorp came to… »   

Widely prescribed for their cholesterol-lowering properties, recent clinical research indicates that statins can produce a second, significant health benefit:… »   

New research being presented at the 2010 FIP Pharmaceutical Sciences World Congress in association with the American Association of Pharmaceutical… »   

A key enzyme in Mycobacterium tuberculosis that enables the microbe to reproduce rapidly could be a golden target for new… »   

Targeted cancer therapies such as trastuzumab (Herceptin), gefitinib (Iressa) and erlotinib (Tarceva) could be used to treat a wider range… »   

Researchers have developed a promising new approach to vaccination for rotavirus, a common cause of severe diarrheal disease that is… »   

Failure to have a prescription filled can undermine medical treatment, result in increased health care costs and potentially have… »   

A half dozen experimental stroke-prevention drugs, and one already on the market, are racing for their share of a… »   

People with mild heart failure lived longer and fared better by adding Pfizer’s drug Inspra to standard medications, a finding… »   

People with egg or gelatin allergies shouldn’t assume that just because they’ve had a flu shot safely in the past… »   

Children are more likely to have an allergy to amoxicillin than adults, according to a study presented at the American… »   

As rival drugs fall by the wayside, Novo Nordisk (NOVOb.CO) is confident Victoza, its new diabetes drug, will be a… »   

GlaxoSmithKline Plc’s (GSK.L) top-selling lung drug Advair is set to enjoy a longer lease of life than widely expected,… »